Key result
Long graft for HVAD-to-HM3 exchange increases high-shear blood volume ~16-fold versus complete exchange.
Why the study?
Retaining part of the HVAD graft during exchange to HM3 alters flow dynamics and pump performance, but its potential theoretical advantages under specific clinical scenarios required evaluation.
How do different surgical techniques for HVAD to HeartMate 3 exchange affect flow dynamics, shear stress, and pressure degradation?
How do different surgical techniques for HVAD to HeartMate 3 exchange affect flow dynamics, shear stress, and pressure degradation?
Retaining the 10-mm HVAD graft during exchange to HeartMate 3 increases shear stress but causes a larger pressure drop that may facilitate aortic valve opening, offering theoretical advantages in specific patient subsets.
Answers are grounded in this paper and cite their sources.
Retaining long grafts may increase shear in models; leaves open optimal HVAD-to-HeartMate 3 exchange technique.
J.G. is a speaker for Abbott. H.G.-G.’s institution receives research grants from Medtronic and Abbott. All other authors reported no conflicts of interest.The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. J.G. is a speaker for Abbott. H.G.-G.’s institution receives research grants from Medtronic and Abbott. All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. We read with great interest the expert review by Salerno and colleagues1Salerno C.T. Hayward C. Hall S. Goldstein D. Saeed D. Schmitto J. et al.HVAD to HeartMate 3 left ventricular assist device exchange: best practices recommendations.J Thorac Cardiovasc Surg. 2022; 163: 2120-2127.e5Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar describing the technical challenges and best practices for managing the HeartWare HVAD (Medtronic) to HeartMate 3 (HM3, Abbott) exchange. The authors do a remarkable job defining the technical challenges and considerations for this operation, and the conclusion from the expert panel is that under optimal clinical scenarios, all components of the HVAD device including the entirety of the 10-mm HVAD outflow graft should be removed through a sternotomy procedure and replaced with the 14-mm HM3 graft. The authors also acknowledge that under certain scenarios, when complete excision of all HVAD components poses an unacceptable surgical risk, an alternative surgical approach involving an anterolateral thoracotomy can be considered, although this technique would necessitate leaving behind a long component of the original HVAD 10-mm graft. The authors rationalize this recommendation by stating that the anterolateral thoracotomy approach leads to remnant HVAD grafted material, which adds resistance to the outflow grafts that would impact pump performance.3Grinstein J. Torii R. Bourantas C.V. Garcia-Garcia H.M. Left ventricular assist device flow pattern analysis using a novel model incorporating left ventricular pulsatility.ASAIO J. 2021; 67: 724-732PubMed Google Scholar The authors are correct in their assertion that retaining the HVAD graft will alter flow through the LVAD by changing the head pressure flow curves for the HM3, although this potentially has theoretical advantages under certain clinical scenarios. Using a combination of lumped-parameter and 3-dimensional computational fluid dynamic models, our group studied the flow dynamics of 4 different HVAD to HM3 surgical techniques: (1) beveled anastomosis near the pump (anterolateral thoracotomy, long 10 mm); (2) beveled anastomosis near the aorta (long 14 mm); (3) beveled anastomosis 5 cm from the aorta (mid transition); and (4) the entire cannula 14 mm (complete exchange, expert panel consensus recommendation).4Hanson S.R. Sakariassen K.S. Blood flow and antithrombotic drug effects.Am Heart J. 1998; 135: S132-S145Crossref PubMed Google Scholar A complete exchange of the outflow cannula had the lowest blood volume exposed to shear rates of greater than 2000 s−1, an upper border of normal physiologic shear rate.5Carmona A. Minh T.H. Perrier S. Schneider C. Marguerite S. Ajob G. et al.Minimally invasive surgery for left ventricular assist device implantation is safe and associated with a decreased risk of right ventricular failure.J Thorac Dis. 2020; 12: 1496-1506Crossref PubMed Scopus (6) Google Scholar A long 10-mm graft achieved through an anterolateral thoracotomy had a 281% larger blood volume exposed to very high shear rates compared with the long 14-mm graft (0.61 mL vs 0.16 mL) and 1464% increase compared with the complete exchange (0.61 mL vs 0.039 mL) (Figure 1). Interestingly, the degradation in pressure down the outflow graft was greater with a lateral thoracotomy approach that leads to retained HVAD graft. At a simulated flow of 6 L/min for all scenarios, there was a modest 2.7 mm Hg decrease in pressure along the cannula with the complete exchange compared with a 14.5 mm Hg decrease in pressure with the anterolateral thoracotomy (Figure 1). The more sizable pressure decrease in the scenarios that retain longer portions of the 10-mm HVAD cannula may actually facilitate more frequent aortic valve opening because this would decrease the aortic transvalvular gradient. Such a pressure decrease may be advantageous in certain patient populations for whom fixed aortic valve closure would be problematic, such as those at risk for progressive aortic insufficiency. Patients with right ventricular dysfunction are also at risk for aortic valve closure secondary to underfilling of the left ventricle. The more sizable pressure decrease with a lateral thoracotomy approach together with the favorable effects that a lateral thoracotomy has on the right ventricle, independent of flow dynamics, may make this the preferred approach for a subset of patients.2Bourque K. Martin M.J. Harjes D.I. Cassidy D.L. Pagani F.D. Kormos R.L. Graft resistance difference after HVAD to HeartMate 3 left ventricular assist device exchange. Ann Thorac Surg.https://doi.org/10.1016/j.athoracsur.2021.11.065Date: 2022Google Scholar HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendationsThe Journal of Thoracic and Cardiovascular SurgeryVol. 163Issue 6PreviewThe HeartWare HVAD System (Medtronic) is a durable implantable left ventricular assist device that has been implanted in approximately 20,000 patients worldwide for bridge to transplant and destination therapy indications. In December 2020, Medtronic issued an Urgent Medical Device Communication informing clinicians of a critical device malfunction in which the HVAD may experience a delay or failure to restart after elective or accidental discontinuation of pump operation. Moreover, evolving retrospective comparative effectiveness studies of patients supported with the HVAD demonstrated a significantly higher risk of stroke and all-cause mortality when compared with a newer generation of a commercially available durable left ventricular assist device.
No takes yet. Share an insight, caveat, or question.
Grinstein et al. (2022) conducted a letter in HeartWare HVAD to HeartMate 3 exchange. Anterolateral thoracotomy with long 10-mm graft vs. Complete exchange (14-mm graft) was evaluated on Blood volume exposed to shear rates >2000 s−1 and pressure degradation. A long 10-mm graft for HVAD to HeartMate 3 exchange increased blood volume exposed to high shear rates and pressure drop compared to complete exchange.
Synapse has enriched 10 related papers. Consider them for comparative context: